How does this lab tools maker earn?
Agilent Technologies Inc makes instruments, software, services, and consumables used in laboratory workflows. Its offerings are used across life sciences and applied markets where labs need repeatable measurement and analytical results. The business is built around installed equipment supported by ongoing services and consumable demand. At roughly USD 32.4 billion in market value, it sits at a scale where consistency matters as much as innovation.
Are margins and cash flow holding steady?
FundamentalsFor the year ended October 31, 2025, reported in USD, revenue reached about USD 6.95 billion, with EBIT of roughly USD 1.48 billion and net income of about USD 1.30 billion. That same period included 6.7% year-over-year revenue growth, alongside a trailing operating margin of 20.40% and a net profit margin of 18.26%.
Cash generation, using the proxy that adjusts EBIT for tax, adds back depreciation and amortization, and subtracts capital spending, came to about USD 1.23 billion. Depreciation and amortization was USD 288 million, while capital spending ran higher at USD 407 million. The balance sheet carried USD 1.79 billion of cash against USD 3.35 billion of total debt.
Is the market overpaying for stability?
DCF / MultiplesAt USD 114.79, the stock trades above the DCF-derived fair value range implied by the weaker-
Durability Priced at a Premium
TakeawayThe business reads like one built for repeatable lab spending. But the current price assumes that durability stays exceptional. Margins and cash conversion need to hold up through cycles. If spending slows or costs rise, the valuation can compress quickly.